Skip to main content

Animations

MJFF Publications

3721 - 3730 of 6515 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: Symptom burden among individuals with Parkinson disease
    Journal Name: Neurology Clinical Practice
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/cpj.0000000000000746
    Citation Count: 49
  • Summary Details
    OPEN
    Title: Transcriptomic signatures of brain regional vulnerability to Parkinson’s disease
    Journal Name: Communications Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s42003-020-0804-9
    Citation Count: 81
  • Summary Details
    OPEN
    Title: A lncRNA survey finds increases in neuroprotective LINC‐PINT in Parkinson’s disease substantia nigra
    Journal Name: Aging Cell
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1111/acel.13115
    Citation Count: 82
  • Summary Details
    OPEN
    Title: Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-019-14279-8
    Citation Count: 474
  • Summary Details
    OPEN
    Title: Fox Insight collects online, longitudinal patient-reported outcomes and genetic data on Parkinson’s disease
    Journal Name: Scientific Data
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41597-020-0401-2
    Citation Count: 108
  • Summary Details
    OPEN
    Title: Safety of Levodopa-Carbidopa Intestinal Gel Treatment in Patients with Advanced Parkinson’s Disease Receiving ≥2000 mg Daily Dose of Levodopa
    Journal Name: Parkinson's Disease
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1155/2020/9716317
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Highly-selective µ-opioid receptor antagonism does not block L-DOPA-induced dyskinesia in a rodent model
    Journal Name: BMC Research Notes
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13104-020-04994-7
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Symptomatic hemiparkinsonism due to extensive middle and posterior fossa arachnoid cyst: case report
    Journal Name: BMC Neurology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12883-020-01670-y
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Executive Function Is Related to the Urinary Urgency in Non-demented Patients With Parkinson’s Disease
    Journal Name: Frontiers in Aging Neuroscience
    Publisher: Frontiers Media SA
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3389/fnagi.2020.00055
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Microglia clear neuron-released α-synuclein via selective autophagy and prevent neurodegeneration
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-020-15119-w
    Citation Count: 517
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.